Bioventus Inc. revised earnings guidance for the full-year 2024. Based on strong execution and significant momentum across the business, Bioventus is raising financial guidance for full-year 2024. The Company now expects Net sales of $535 million to $550million, an increase of $15 million from previous guidance.